Bachem Holding AG (LON:0QND)

Market Cap	3.75B
Revenue (ttm)	622.20M
Net Income (ttm)	123.16M
Shares Out	n/a
EPS (ttm)	1.65
PE Ratio	30.41
Forward PE	26.77
Dividend	0.78 (1.47%)
Ex-Dividend Date	May 5, 2025

Volume	1,057
Average Volume	28,017
Open	53.60
Previous Close	53.30
Day's Range	52.73 - 53.60
52-Week Range	43.98 - 76.00
Beta	1.01
RSI	48.42
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF